Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cashflow Statement

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹504 Cr₹424 Cr₹338 Cr₹248 Cr₹302 Cr
Adjustment ₹69 Cr₹55 Cr₹74 Cr₹35 Cr₹57 Cr
Changes In working Capital ₹-241 Cr₹-126 Cr₹-111 Cr₹-111 Cr₹-132 Cr
Cash Flow after changes in Working Capital ₹333 Cr₹353 Cr₹300 Cr₹172 Cr₹227 Cr
Cash Flow from Operating Activities ₹207 Cr₹230 Cr₹237 Cr₹99 Cr₹179 Cr
Cash Flow from Investing Activities ₹-49 Cr₹-141 Cr₹-259 Cr₹-84 Cr₹-45 Cr
Cash Flow from Financing Activities ₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr₹-15 Cr
Net Cash Inflow / Outflow ₹93 Cr₹21 Cr₹176 Cr₹94 Cr₹118 Cr
Opening Cash & Cash Equivalents ₹403 Cr₹382 Cr₹206 Cr₹112 Cr₹94 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations --₹0.00 Cr--
Closing Cash & Cash Equivalent ₹496 Cr₹403 Cr₹382 Cr₹206 Cr₹212 Cr

Compare Cashflow Statement of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,378.1 Cr -4.1% -6.5% -24% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.1%

-6.5%

-24%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses